Urology Medical News about Tolterodine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The effect of antimuscarinics on bladder filling sensations in healthy subjects - A placebo controlled double blind investigation using 4 and 8 mg tolterodine extended release
Neurourology and Urodynamics, 07/29/09

Mehnert U et al. – No increase of filling volumes in healthy subjects could be observed with tolterodine. However, the results suggest that tolterodine is able to alleviate irritation caused by repeated catheterization and cystometry. There was no significant influence of tolterodine ER 4 or 8 mg on voiding function.

<< Previous
The clinical significance of rectal contractions that occur...

Next >>
Partners agree that the treatment of LUTS reduces patients bother...

The Effects of Tolterodine Extended Release and Alfuzosin for the Treatment of Double-J Stent-Related Symptoms
Journal of Endourology, 10/12/09 Relevance Score: 87%

Fesoterodine for the Treatment of Overactive Bladder
Annals of Pharmacotherapy, 11/18/09 Relevance Score: 82%

Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/05/09 Relevance Score: 80%

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09 Relevance Score: 80%